Consistent with this, data from TCGA show that CACNA2D4 expression is significantly decreased in tumour versus normal tissue (Figure S11B); however, we were unable to assess the corresponding methylation difference in the same cohort as the HM450K platform used by TCGA does not have probes targeting the CACNA2D4 DMR. Here, CACNA2D4 is linked to neoplasm.